The mechanism of action of CX-3543 is based on targeting and disruption of nucleolin/rDNA G-quadruplex complexes resulting in the inhibition of Pol I transcription and in the apoptosis induction in cancer cells [88]. Here, NUCLEOLIN is linked to cancer.